Kimberly Stegmaier, M.D.

Ted Williams Chair and Vice Chair of Pediatric Oncology Research, Dana-Farber Cancer Institute
Co-Director, Pediatric Hematologic Malignancy Program
Associate Professor of Pediatrics, Harvard Medical School
Institute Member, Broad Institute of MIT and Harvard
Boston, Mass.

Kimberly Stegmaier, an Associate Professor of Pediatrics at Harvard Medical School and the Ted Williams Chair at Dana-Farber Cancer Institute (DFCI), has advanced the application of genomics to drug and protein target discovery for pediatric cancers.  She is the Vice Chair for Pediatric Oncology Research and Co-director of the Pediatric Hematologic Malignancy Program at the Dana-Farber Cancer Institute and Boston Children’s Hospital. Dr. Stegmaier is also an Institute Member of the Broad Institute of Harvard and MIT.

The Stegmaier laboratory develops and integrates chemical and functional genomic approaches to identify new protein targets and small-molecule modulators of malignancy with an eye toward clinical translation. The laboratory has focused on pediatric malignancies notable for the aberrancy of differentiation and/or oncogenic activation of transcription factors: the acute leukemias, neuroblastoma, and Ewing sarcoma. Multiple clinical trials have resulted from her laboratory’s research. Dr. Stegmaier has won numerous awards for her work, including the SPR Young Investigator Award, the Sir William Osler Young Investigator Award from the Interurban Clinical Club, a SU2C Innovative Research Grant, the 2016 E. Mead Johnson Award for Research in Pediatrics, an NCI Outstanding Investigator Award and the 2017 St. Baldrick’s Foundation Robert J. Arceci Innovation Award.

Dr. Stegmaier was elected to the Society for Pediatric Research in 2007, the American Society for Clinical Investigation in 2009, and the Association of American Physicians in 2017. She is a strong advocate for pediatric research, serving as a Council Member with the Society for Pediatric Research from 2013-2016 and now as the Chair Elect for the AACR Pediatric Cancer Working Group. She was awarded the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School for her commitment to training the next generation of pediatric cancer researchers.

Dr. Stegmaier received her undergraduate degree from Duke University, medical degree from Harvard Medical School, and trained in Pediatrics and Pediatric Hematology/Oncology at Boston Children’s Hospital and the Dana-Farber Cancer Institute.

 


Related Sessions

View full schedule